German cross-country skier Victoria Carl tested positive for a banned substance prohibited by the World Anti-Doping Agency ...

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase 2b trial, putting it in hot pursuit of Merck & Co's gefapixant, which was filed for approval in March.

"The chronic cough market, valued at $17 billion and growing at 6.39% annually, represents a significant opportunity for digital therapeutics to transform care while reducing healthcare costs and ...

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays.

A new COVID variant called "Nimbus" is spreading. Here's what you need to know about the incubation period, symptoms ...

Discover the best CBD gummies our editors have tried. We tested over 150 CBD gummies based on quality and transparency—learn more about our top five picks here.

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

“The hot drink provided immediate and sustained relief from symptoms of runny nose, cough, sneezing, sore throat, chilliness, and tiredness, whereas the same drink at room temperature only ...